Literature DB >> 16716992

Predictive value of S-100B protein and neuron specific-enolase as markers of traumatic brain damage in clinical use.

Zahra S Naeimi1, Alexandra Weinhofer, Kambiz Sarahrudi, Thomas Heinz, Vilmos Vécsei.   

Abstract

OBJECTIVE: S-100B and NSE proteins are considered to be neurobiochemical markers for the brain damage. The aim of this study was to consider the diagnostic and prognostic validity of the initial serum levels of S-100B and NSE in clinical use.
METHODS: Forty-five patients with traumatic brain injury were included in this prospective study. Neurologic examination and CCT-scan were performed. S-100B and NSE were analysed. Patients were divided in two groups depending on the severity of injury.
RESULTS: The results showed a significant difference between the S-100B serum concentration and the two groups-minor head injuries and severe head injuries. A statistically significant correlation was observed between an increase of S-100B and NSE serum values and a cerebral pathological finding in CT scans.
CONCLUSION: The clear correlation between S-100B and NSE serum concentrations and CCT findings does not validate both markers as an independent predictor of diagnosis and prognosis of brain injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716992     DOI: 10.1080/02699050600664418

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  15 in total

1.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Jay L Falk; Zhiqun Zhang; Salvatore Silvestri; Philip Giordano; Gretchen M Brophy; Jason A Demery; Neha K Dixit; Ian Ferguson; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Kara Schmid; Stefania Mondello; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Ann Emerg Med       Date:  2011-11-08       Impact factor: 5.721

2.  Chronic Traumatic Encephalopathy in Athletes Involved with High-impact Sports.

Authors:  Cyrus Safinia; Eric M Bershad; H Brent Clark; Karen SantaCruz; Naila Alakbarova; Jose I Suarez; Afshin A Divani
Journal:  J Vasc Interv Neurol       Date:  2016-10

Review 3.  The Biological Basis of Chronic Traumatic Encephalopathy following Blast Injury: A Literature Review.

Authors:  Matt Aldag; Regina C Armstrong; Faris Bandak; Patrick S F Bellgowan; Timothy Bentley; Sean Biggerstaff; Katrina Caravelli; Joan Cmarik; Alicia Crowder; Thomas J DeGraba; Travis A Dittmer; Richard G Ellenbogen; Colin Greene; Raj K Gupta; Ramona Hicks; Stuart Hoffman; Robert C Latta; Michael J Leggieri; Donald Marion; Robert Mazzoli; Michael McCrea; John O'Donnell; Mark Packer; James B Petro; Todd E Rasmussen; Wendy Sammons-Jackson; Richard Shoge; Victoria Tepe; Ladd A Tremaine; James Zheng
Journal:  J Neurotrauma       Date:  2017-09       Impact factor: 5.269

4.  Mild Traumatic Brain Injury among the Geriatric Population.

Authors:  Linda Papa; Matthew E Mendes; Carolina F Braga
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-09-01

5.  Does serum osmolarity change as a result of the reflex neuroprotective mechanism of cerebral osmo-regulation after minor head trauma?

Authors:  Naci Balak; Nilgün Isiksacan; Recai Turkoglu
Journal:  J Korean Neurosurg Soc       Date:  2009-03-31

6.  Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.

Authors:  Linda Papa; Claudia S Robertson; Kevin K W Wang; Gretchen M Brophy; H Julia Hannay; Shelley Heaton; Ilona Schmalfuss; Andrea Gabrielli; Ronald L Hayes; Steven A Robicsek
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

Review 7.  Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers.

Authors:  Steven T DeKosky; Kaj Blennow; Milos D Ikonomovic; Sam Gandy
Journal:  Nat Rev Neurol       Date:  2013-04       Impact factor: 42.937

8.  Primary study for the therapeutic dose and time window of picroside II in treating cerebral ischemic injury in rats.

Authors:  Haitao Pei; Xi Su; Li Zhao; Hongyun Li; Yunliang Guo; Menizeng Zhang; Hui Xin
Journal:  Int J Mol Sci       Date:  2012-02-23       Impact factor: 6.208

9.  Application of blood-based biomarkers in human mild traumatic brain injury.

Authors:  Alex P Di Battista; Shawn G Rhind; Andrew J Baker
Journal:  Front Neurol       Date:  2013-05-01       Impact factor: 4.003

10.  The effect of doxycycline on neuron-specific enolase in patients with traumatic brain injury: a randomized controlled trial.

Authors:  Noha O Mansour; Mohamed A Shama; Rehab H Werida
Journal:  Ther Adv Chronic Dis       Date:  2021-06-23       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.